3719 Results

People

  1. Hudis
    Hudis
  2. Lee
    Lee
  3. Giralt
    Giralt
  4. Motzer
    Motzer
  5. Barakat
    Barakat
  6. Scher
    Scher
  7. Ladanyi
    Ladanyi
  8. Levine
    Levine
  9. Chi
    Chi
  10. DeMatteo
    DeMatteo

Groups

  1. Department of Medicine (1284)
  2. Surgery (899)
  3. GSK Faculty (811)
  4. Solid Tumor Oncology Division (708)
  5. Survivorship Research (632)
  6. Sloan Kettering Institute Faculty (579)
  7. Center for Hematologic Malignancies (503)
  8. Department of Pathology and Laboratory Medicine (470)
  9. Population Sciences Research Program (431)
  10. Epidemiology and Biostatistics (426)
  1. "2012"
Formats
  1. Journal Article (2365)
  2. Meeting Abstract (1182)
  3. Book Section (137)
  4. Conference Paper (23)
  5. Book Whole (10)
  6. Correspondence (1)
  7. Editorial (1)
Groups
  1. Department of Medicine (1284)
  2. Surgery (899)
  3. GSK Faculty (811)
  4. Solid Tumor Oncology Division (708)
  5. Survivorship Research (632)
  6. Sloan Kettering Institute Faculty (579)

More Groups

People
  1. Clifford Hudis (64)
  2. Nancy Lee (64)
  3. Sergio Giralt (59)
  4. Robert Motzer (57)
  5. Richard Barakat (54)
  6. Howard Scher (53)

More People

Years
  1. 2012 (3719)
Publications
  1. Journal of Clinical Oncology (315)
  2. Blood (152)
  3. International Journal of Radiation Oncology, Biology, Physics (125)
  4. Cancer Research (110)
  5. Modern Pathology (80)
  6. Gynecologic Oncology (76)

More Publications

Publishers
  1. Elsevier Inc. (519)
  2. American Society of Clinical Oncology (337)
  3. Springer (239)
  4. Nature Publishing Group (202)
  5. Wiley Blackwell (193)
  6. American Association for Cancer Research (192)

More Publishers

Results (3719)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparison of the KRAS/EGFR mutation profile and survival of "collegiate smokers" and never smokers with advanced lung cancers
    Meeting Abstract

    Varghese, A. M.; Sima, C. S.; Chaft, J. E.; Johnson, M. L.; Janjigian, Y. Y.; Drilon, A. E. D.; Yu, H. A.; Riely, G. J.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Genetic determinants of long-term response to rapalog therapy in advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Scott, S. N.; Takeda, S.; Liu, H.; Chen, Y.; Motzer, R. J.; Berger, M. F.; Hsieh, J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Contribution of diet and physical activity to metabolic parameters among survivors of childhood leukemia
    Meeting Abstract

    Tonorezos, E. S.; Kent, D. A.; Moskowitz, C. S.; Oeffinger, K. C.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Safety of ipilimumab in patients (pts) with untreated, advanced melanoma alive beyond 2 years: Results from a phase III study
    Meeting Abstract

    Thomas, L.; Wolchok, J. D.; Garbe, C.; Lebbe, C.; Bondarenko, I.; Rodrigues, K.; Konto, C.; Chin, K. M.; Francis, S.; Robert, C.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • IBL2001: Phase (ph) I/II study of a novel dose-dense (dd) schedule of indibulin for the treatment of metastastic breast cancer
    Meeting Abstract

    Traina, T. A.; Hudis, C.; Gonzalez, J.; Anthony, S. P.; Smith, D. A.; Chandler, J. C.; Jac, J.; Youssoufian, H.; Norton, L.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • The value of personalizing medicine: Medical oncologists' and patients' perspectives on genomic testing of breast tumors in chemotherapy treatment decisions
    Meeting Abstract

    Trudeau, M. E.; Bombard, Y.; Rozmovits, L.; Leighl, N. B.; Deal, K.; Marshall, D.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • ALK and MET genes in advanced lung adenocarcinomas: The Lung Cancer Mutation Consortium experience
    Meeting Abstract

    Varella-Garcia, M.; Berry, L. D.; Su, P. F.; Franklin, W. A.; Iafrate, A. J.; Ladanyi, M.; Camidge, D. R.; Garon, E. B.; Haura, E. B.; Horn, L.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II study of ADI-PEG 20 in patients with relapsed sensitive or refractory small cell lung cancer
    Meeting Abstract

    Tran, S.; Ready, N.; Krug, L. M.; Pietanza, M. C.; Jungbluth, A. A.; Pan, L. S.; Venhaus, R. R.; Hoffman, E. W.; Peters, A. M.; Dukelow, K.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A phase II, single-arm, feasibility study of dose-dense doxorubicin and cyclophosphamide (AC) followed by eribulin mesylate for the adjuvant treatment of early-stage breast cancer (EBC)
    Meeting Abstract

    Traina, T. A.; Hudis, C.; Lehman, R.; Rege, J.; Wang, W.; Cox, D.; Seidman, A. D.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Is there any significant difference between tumor regression grade systems of rectal cancer?
    Meeting Abstract

    Trakarnsanga, A.; Gonen, M.; Shia, J.; Nash, G. M.; Temple, L. K. F.; Guillem, J. G.; Paty, P.; Goodman, K. A.; Gollub, M.; Saltz, L.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save